Vitalhub (VHI) AI Stock Analysis

• Market Cap: C$672.05M
• Dividend Yield: N/A
• Average Volume (3M): 115.66K
• Price to Earnings (P/E): 229.2
• Beta (1Y): 0.50
• Revenue Growth: 35.97%
• EPS Growth: -59.04%
• Country: CA
• Employees: 500
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 0.02
• Shares Outstanding: 54,816,837
• 10 Day Avg. Volume: 137,387
• 30 Day Avg. Volume: 115,664
• PEG Ratio: -15.04
• Price to Book (P/B): 3.78
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 44.61
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: C$14.70
• Price Target Upside: 19.90% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 5

• Rating: 75 Outperform
• Price Target: C$14.00 ▲(14.19%Upside)

Vitalhub scores well due to its strong financial performance and strategic acquisitions that bolster its market position. However, the high valuation compared to industry standards and overbought technical indicators suggest caution. The company's growth trajectory remains promising, but investors should be mindful of potential risks associated with its current valuation.

Vitalhub Business Overview & Revenue Model

Company Description

Vitalhub (VHI) is a technology company that specializes in developing and implementing software solutions for the healthcare sector. The company focuses on providing innovative tools that improve the efficiency and effectiveness of healthcare delivery. Its core products and services include electronic health records (EHR), patient flow management, mental health software, and other integrated care solutions aimed at enhancing the quality of care and operational performance within healthcare organizations.

How the Company Makes Money

Vitalhub makes money primarily through the sale of its software solutions to healthcare providers. The company's revenue model includes licensing fees, subscription fees, and service contracts for its software products. Key revenue streams involve long-term contracts with hospitals, mental health organizations, and other healthcare facilities that utilize Vitalhub's technology to streamline their operations and improve patient care. Additionally, Vitalhub may generate revenue through strategic partnerships with other technology firms and healthcare providers, which can expand its market reach and offer integrated solutions to clients.

Vitalhub Financial Statement Overview

Summary

Vitalhub demonstrates robust revenue growth and strong gross profit margins, with a solid balance sheet characterized by low leverage and substantial equity. Cash flow generation is effective, albeit with room for improving free cash flow efficiency. Overall, the financials reflect a well-managed company with a strong growth trajectory.

Income Statement

Vitalhub demonstrates robust revenue growth with a TTM (Trailing-Twelve-Months) revenue increase from the previous year. The gross profit margin is strong at approximately 78.2%, indicating efficient cost management. Net profit margin, while positive, is moderate at 3.8%, signaling room for improvement in profitability. The EBIT and EBITDA margins are healthy, reflecting good operational efficiency.

Balance Sheet

The balance sheet is strong, with a low debt-to-equity ratio of approximately 0.004, indicating minimal leverage and financial risk. The return on equity (ROE) is modest at 1.6%, suggesting potential for higher profitability. The equity ratio is high at 73.4%, highlighting a solid capital structure with significant equity backing.

Cash Flow

Vitalhub's cash flow position is solid, with a high positive operating cash flow. The free cash flow has grown, reflecting effective cash generation. The operating cash flow to net income ratio is robust, indicating strong cash earnings relative to reported income. However, the free cash flow to net income ratio shows some room for improvement, suggesting potential efficiency gains in cash usage.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	68.59M	52.51M	39.97M	24.66M	13.79M
Gross Profit	55.49M	42.81M	32.94M	19.43M	10.29M
EBITDA	11.90M	10.38M	5.25M	1.12M	148.12K
Net Income	3.00M	4.55M	1.21M	-1.95M	-2.17M
Balance Sheet
Total Assets	207.19M	118.78M	106.19M	72.77M	64.08M
Cash, Cash Equivalents and Short-Term Investments	56.57M	33.48M	17.45M	16.39M	23.39M
Total Debt	608.76K	541.09K	882.20K	792.51K	987.89K
Total Liabilities	62.33M	36.88M	30.79M	17.95M	13.77M
Stockholders Equity	144.86M	81.91M	75.40M	54.82M	50.31M
Cash Flow
Free Cash Flow	14.24M	20.18M	5.83M	-309.58K	294.35K
Operating Cash Flow	15.13M	20.47M	6.12M	-49.97K	405.14K
Investing Cash Flow	-31.39M	-4.15M	-21.84M	-10.06M	-9.37M
Financing Cash Flow	39.09M	-287.89K	16.40M	3.17M	30.37M

Vitalhub Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 12.26
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:VHI, the sentiment is Positive. The current price of 12.26 is above the 20-day moving average (MA) of 11.59, above the 50-day MA of 10.97, and above the 200-day MA of 10.61, indicating a bullish trend. The MACD of 0.43 indicates Negative momentum. The RSI at 64.72 is Neutral, neither overbought nor oversold. The STOCH value of 72.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:VHI.

Vitalhub Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
VHI	75 Outperform	C$672.05M	229.16	2.15%	―	35.97%	-59.04%
KSI	67 Neutral	C$549.71M	―	-4.56%	―	42.93%	85.95%
AIML	55 Neutral	C$9.53M	―	-244.35%	―	-71.31%	-53.11%
Sector *	52 Neutral	$7.36B	-0.07	-63.77%	2.36%	16.35%	0.03%
ADK	51 Neutral	C$22.41M	―	366.78%	―	-39.00%	-11.21%
UDOC	34 Underperform	C$17.55M	―	-9999.00%	―	―	-50.06%
TRUE	34 Underperform	C$32.09M	―	-507.20%	―	-171.18%	46.80%

Vitalhub Corporate Events

VitalHub Acquires Novari Health to Strengthen Market Position

VitalHub Corp. has announced the acquisition of Novari Health Inc., a Canadian healthcare software provider specializing in patient flow solutions, for $43.6 million with potential additional performance-based payments. This acquisition is expected to bolster VitalHub’s position in the Canadian market and facilitate global expansion, particularly in the UK, by leveraging Novari’s established technologies and VitalHub’s international presence, enhancing value for customers and stakeholders.

The most recent analyst rating on (TSE:VHI) stock is a Buy with a C$10.50 price target. To see the full list of analyst forecasts on Vitalhub stock, see the TSE:VHI Stock Forecast page.

VitalHub Announces Successful Election of Directors and Auditor Appointment

VitalHub Corp. announced the results of its annual general meeting, where all director nominees were elected to the board, and MNP LLP was appointed as auditors. The meeting saw a 60.45% participation rate of the total shares issued and outstanding. These developments reinforce VitalHub’s governance structure and ensure continued oversight and financial integrity, which are crucial for its ongoing growth and market positioning.

The most recent analyst rating on (TSE:VHI) stock is a Buy with a C$10.50 price target. To see the full list of analyst forecasts on Vitalhub stock, see the TSE:VHI Stock Forecast page.

VitalHub Completes Strategic Acquisition of Induction Healthcare

VitalHub has completed the acquisition of Induction Healthcare Group PLC, enhancing its product offerings with Induction’s software solutions like Zesty and Attend Anywhere. This acquisition, valued at approximately £9.7 million, is expected to complement VitalHub’s existing solutions, improve healthcare partner value, and enhance patient outcomes, thereby strengthening its position in the healthcare software industry.

The most recent analyst rating on (TSE:VHI) stock is a Buy with a C$10.50 price target. To see the full list of analyst forecasts on Vitalhub stock, see the TSE:VHI Stock Forecast page.

VitalHub Files Preliminary Base Shelf Prospectus for Future Securities Offerings

VitalHub Corp. has filed a preliminary short form base shelf prospectus with securities regulatory authorities in Alberta, British Columbia, and Ontario. This filing, once finalized, will allow the company to qualify the distribution of up to $250 million in various securities over a 25-month period. Although VitalHub has no immediate plans to offer securities under this prospectus, the move positions the company to quickly capitalize on future opportunities, potentially impacting its financial strategy and market positioning.

The most recent analyst rating on (TSE:VHI) stock is a Buy with a C$10.50 price target. To see the full list of analyst forecasts on Vitalhub stock, see the TSE:VHI Stock Forecast page.

VitalHub Achieves Robust Q1 2025 Growth and Eyes Strategic Acquisition

VitalHub Corp. reported significant financial growth in the first quarter of 2025, with a 54% year-over-year increase in Annual Recurring Revenue (ARR) to $73.7 million and a 42% rise in total revenue to $21.7 million. The company is strengthening its infrastructure and exploring strategic acquisitions, including a potential cash acquisition of UK-based Induction Healthcare Group, expected to close in the third quarter of 2025. This acquisition, along with other opportunities in the pipeline, is anticipated to provide strong synergistic value and enhance VitalHub’s market positioning.

VitalHub to Release Q1 2025 Financial Results and Host Conference Call

VitalHub Corp. has announced it will release its Q1 2025 financial results on May 8, 2025, followed by a conference call on May 9, 2025. This announcement is part of VitalHub’s ongoing efforts to engage with stakeholders and provide transparency about its financial performance, which could impact its market positioning and investor relations.